ABBOTT LABORATORIES Stockholders' Equity 2006-2026 | ABT
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is ABBOTT LABORATORIES's current stockholders' equity?
ABBOTT LABORATORIES (ABT) annual stockholders' equity for 2025 was $52.13B, a 9.37% increase from 2024. ABBOTT LABORATORIES stockholders' equity for the quarter ending March 31, 2026 was $52.06B.
What was ABBOTT LABORATORIES's stockholders' equity in 2024?
ABBOTT LABORATORIES annual stockholders' equity for 2024 was $47.66B, a 23.47% increase from 2023.
What was ABBOTT LABORATORIES's stockholders' equity in 2023?
ABBOTT LABORATORIES annual stockholders' equity for 2023 was $38.60B, a 5.23% increase from 2022.
What is ABBOTT LABORATORIES's 5-year stockholders' equity CAGR?
ABBOTT LABORATORIES stockholders' equity grew at a compound annual growth rate (CAGR) of 9.72% from FY2020 to FY2025, going from $32.78B to $52.13B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $52.13B | +9.4% | 10-K |
| FY2024 | $47.66B | +23.5% | 10-K |
| FY2023 | $38.60B | +5.2% | 10-K |
| FY2022 | $36.69B | +2.5% | 10-K |
| FY2021 | $35.80B | +9.2% | 10-K |
| FY2020 | $32.78B | +5.5% | 10-K |
| FY2019 | $31.09B | +1.8% | 10-K |
| FY2018 | $30.52B | -1.2% | 10-K |
| FY2017 | $30.90B | +50.4% | 10-K |
| FY2016 | $20.54B | -3.2% | 10-K |
| FY2015 | $21.21B | -1.5% | 10-K |
| FY2014 | $21.53B | -14.5% | 10-K |
| FY2013 | $25.17B | -5.8% | 10-K |
| FY2012 | $26.72B | +9.3% | 10-K |
| FY2011 | $24.44B | +7.8% | 10-K |
| FY2010 | $22.68B | -2.0% | 10-K |
| FY2009 | $23.14B | +32.4% | 10-K |
| FY2008 | $17.48B | -1.9% | 10-K |
| FY2007 | $17.82B | +26.8% | 10-K |
| FY2006 | $14.05B | - | 10-K |